-
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
18 Jun 2024 16:22 GMT
Dive Brief:
The Food and Drug Administration on Monday approved a … two pneumococcal vaccines. One, dubbed Pneumovax 23, is for adults at …
-
FDA says yes to MSD’s 21-valent adult pneumococcal jab
18 Jun 2024 12:13 GMT
… up a notch with the FDA approval of MSD’s new … sells an older shot called Pneumovax 23, which covers 23 serotypes …
-
DR. PETER CHOW: ‘No family doctor! Bye-Bye! Die! Die!’
31 May 2024 20:42 GMT
… medicine is to deny the existence of any crisis outright, stating … for shingles and Pneumovax for pneumococcal pneumonia. … medical students are picking family medicine, a large number of baby-boomer doctors … new drugs and therapeutics and medical technology …
-
Merck touts updated 21-valent pneumococcal data weeks ahead of FDA decision: Corrected
29 Apr 2024 20:25 GMT
Merck bolstered its pneumococcal vaccine data on Monday, as the company looks to one-up Pfizer’s Prevnar 20 shot.
Merck said that its new conjugate vaccine, called V116, proved noninferior to its much older Pneumovax 23 vaccine for …
-
Merck reports positive data from STRIDE─10 phase 3 trial of V116, an investigational, 21─valent pneumococcal conjugate vaccine specifically designed for adults
02 May 2024 07:18 GMT
… in Barcelona, Spain. The trial evaluated the immunogenicity, tolerability … build upon phase 3 trial results that were … Food and Drug Administration (FDA) and the European Medicines Agency (EMA). … and STRIDE-10 (NCT05569954).
Pneumovax 23 is a vaccine indicated …
-
Human medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Date of authorisation: 14/02/2022, Revision: 7, Status: Authorised
12 Mar 2024 17:08 GMT
Studies in adults
In 2 main studies, Prevenar 20 was shown to trigger immune responses that were comparable to those triggered by two other authorised pneumococcal vaccines (Prevenar 13, a vaccine that protects against 13 types of S. pneumoniae; Pneumovax …
-
GPN vaccines announces positive safety and immunogenicity data from its phase 1 trial of Gamma─PN
05 Jan 2024 08:56 GMT
… a clinical-stage biotechnology company developing a Streptococcus … of licensed pneumococcal vaccine (Pneumovax-23 or Prevenar 13 … , GPN Vaccines’ chief medical officer commented “I would … Phase 2 clinical trials”.
This trial was generously supported …
-
Merck gets FDA decision date for new pneumococcal vaccine
19 Dec 2023 17:26 GMT
… , supplements the pharmaceutical company’s older Pneumovax 23 product.
… two late-stage clinical trials, one of which … .
The FDA grants priority review to drugs and therapeutics … treatment or prevention of serious conditions.
Elsewhere, GSK and biotechnology …
-
Doctor’s Tip: Influenza can interrupt work and school, but it can also cause death. It’s flu shot time.
14 Sep 2023 23:53 GMT
Dr. Greg Feinsinger
Doctor';s Tip
It has … can be obtained in most doctors’ offices, pharmacies, and at public …
Rapid flu tests done in doctors’ offices are helpful for diagnosis … given concurrently with flu shots), Pneumovax (“pneumonia shots”) and shingles.
-
Statistics Report: Global Varicose Veins Treatment Market Share & Sales Expected to Surpass USD 1450 Million by 2030: Growing number of patients suffering from varicose veins to propel market growth - Predicts Facts & Factors
08 Feb 2023 12:49 GMT
… . During diagnosis, the doctors generally examine the legs … to higher accessibility to medical treatment as well as growing … Authorities), By Product Type (Pneumovax 23, Synflorix, and … Beverages, Animal Feed, and Pharmaceuticals) and By Operability (Gut …
About
© 1995-2025